| Dr Clio Armitage Harper Iii, MD | |
|
801 W 38th St, Suite 200, Austin, TX 78705-1169 | |
| (512) 451-0103 | |
| (512) 451-2741 |
| Full Name | Dr Clio Armitage Harper Iii |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 36 Years |
| Location | 801 W 38th St, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013989706 | NPI | - | NPPES |
| 86X320 | Other | TX | BCBSTX |
| 135843408 | Medicaid | TX | |
| 180024010 | Other | TX | RAILROAD MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Seton Medical Center Austin | Austin, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Austin Retina Associates Pllc | 2163497801 | 12 |
News Archive
A team of researchers at the NIHR Leicester Biomedical Research Centre, UK - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University - has concluded that middle-aged people who report that they are slow walkers could be at higher risk of heart disease compared to the general population.
mPhase Technologies, Inc. said today that it is pursuing licensing opportunities for its Smart Drug Delivery System.
Quotient Biodiagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved its biologics license application (BLA) for the first 15 monoclonal antibodies in its proprietary line of transfusion diagnostics. These products are for use by blood donor centers, reference laboratories, and hospitals to type and screen blood.
Doing a little detective work can go a long way in finding skin cancer, the most common form of cancer diagnosed in the United States, at its earliest, most treatable stage. However, a new survey found that many people do not know how to spot skin cancer and are unaware of their risk of developing the disease.
› Verified 6 days ago
| Entity Name | Austin Retina Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033183561 PECOS PAC ID: 2163497801 Enrollment ID: O20040827000054 |
News Archive
A team of researchers at the NIHR Leicester Biomedical Research Centre, UK - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University - has concluded that middle-aged people who report that they are slow walkers could be at higher risk of heart disease compared to the general population.
mPhase Technologies, Inc. said today that it is pursuing licensing opportunities for its Smart Drug Delivery System.
Quotient Biodiagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved its biologics license application (BLA) for the first 15 monoclonal antibodies in its proprietary line of transfusion diagnostics. These products are for use by blood donor centers, reference laboratories, and hospitals to type and screen blood.
Doing a little detective work can go a long way in finding skin cancer, the most common form of cancer diagnosed in the United States, at its earliest, most treatable stage. However, a new survey found that many people do not know how to spot skin cancer and are unaware of their risk of developing the disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clio Armitage Harper Iii, MD 1512 W 35th St Ste 200, Austin, TX 78703-1437 Ph: (512) 451-0103 | Dr Clio Armitage Harper Iii, MD 801 W 38th St, Suite 200, Austin, TX 78705-1169 Ph: (512) 451-0103 |
News Archive
A team of researchers at the NIHR Leicester Biomedical Research Centre, UK - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University - has concluded that middle-aged people who report that they are slow walkers could be at higher risk of heart disease compared to the general population.
mPhase Technologies, Inc. said today that it is pursuing licensing opportunities for its Smart Drug Delivery System.
Quotient Biodiagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved its biologics license application (BLA) for the first 15 monoclonal antibodies in its proprietary line of transfusion diagnostics. These products are for use by blood donor centers, reference laboratories, and hospitals to type and screen blood.
Doing a little detective work can go a long way in finding skin cancer, the most common form of cancer diagnosed in the United States, at its earliest, most treatable stage. However, a new survey found that many people do not know how to spot skin cancer and are unaware of their risk of developing the disease.
› Verified 6 days ago
Dr. Kristen Michelle Hawthorne, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2610 S Ih 35, Austin, TX 78704 Phone: 512-443-9715 Fax: 512-443-9845 | |
Saradha Chexal, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3705 Medical Pkwy Ste 460, Austin, TX 78705 Phone: 512-454-5851 | |
Dr. John David Fisher, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2901 Montopolis Dr, Austin, TX 78741 Phone: 512-389-6571 Fax: 512-389-6511 | |
Dr. Nadja Ivette Torres, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2610 S Ih 35, Austin, TX 78704 Phone: 512-443-9715 Fax: 512-443-9845 | |
Fuad Makkouk, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9707 Anderson Mill Rd Ste 230, Austin, TX 78750 Phone: 512-693-9363 | |
Irina Volosko, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3410 Far West Blvd Ste 140, Austin, TX 78731 Phone: 512-427-1107 Fax: 512-427-1207 |